| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.00047 | 1 |